Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Iterum Therapeutics plc (ITRM)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
22 Dec 2023
Dunne Michael W.
Director
Iterum Therapeutics plc
(ITRM)
113,754
+28%
25,000
$1.40
$35,000.00
BUY
18 Dec 2023
Dunne Michael W.
Director
Iterum Therapeutics plc
(ITRM)
88,754
+12%
10,000
$1.84
$18,442.00
BUY
20 Nov 2023
Fishman Corey N.
Chief Executive Officer, Director, Officer
Iterum Therapeutics plc
(ITRM)
54,449
+22%
10,000
$1.59
$15,863.00
SELL
1 Dec 2022
Puttagunta Sailaja
Chief Medical Officer, Officer
Iterum Therapeutics plc
(ITRM)
4,969
-40%
3,365
$1.32
$4,441.80
SELL
16 Sep 2022
Ahrens Brenton Karl
Director
Iterum Therapeutics plc
(ITRM)
0
-100%
37,246
$1.82
$67,930.20
SELL
13 Sep 2022
Ahrens Brenton Karl
Director
Iterum Therapeutics plc
(ITRM)
37,246
-54%
45,000
$2.09
$93,846.00
SELL
8 Sep 2022
Ahrens Brenton Karl
Director
Iterum Therapeutics plc
(ITRM)
82,246
-28%
33,298
$2.31
$76,802.52
BUY
7 Sep 2022
Dunne Michael W.
Director
Iterum Therapeutics plc
(ITRM)
35,576
+39%
10,000
$2.22
$22,200.00
SELL
11 Mar 2022
Matthews Judith M.
Chief Financial Officer, Officer
Iterum Therapeutics plc
(ITRM)
81,500
-36%
47,132
$0.38
$17,910.16
SELL
11 Feb 2021
DENNER ALEXANDER J
10% Owner
Iterum Therapeutics plc
(ITRM)
0
-100%
20,619,948
$2.43
$50,007,284.00
SELL
25 Jan 2021
Dunne Michael W.
Director
Iterum Therapeutics plc
(ITRM)
256,355
-11%
33,143
$1.73
$57,337.39
SELL
25 Jan 2021
Fishman Corey N.
President & CEO, Director, Officer
Iterum Therapeutics plc
(ITRM)
322,008
-20%
85,445
$1.73
$147,819.86
SELL
25 Jan 2021
Matthews Judith M.
Chief Financial Officer, Officer
Iterum Therapeutics plc
(ITRM)
28,632
-54%
33,868
$1.73
$58,591.64
SELL
30 Sep 2020
Matthews Judith M.
Chief Financial Officer, Officer
Iterum Therapeutics plc
(ITRM)
0
-100%
56,130
$1.64
$92,053.20
SELL
1 Jun 2020
Sofinnova Venture Partners IX, L.P.
10% Owner
Iterum Therapeutics plc
(ITRM)
1,226,514
-28%
500,000
$1.62
$812,080.00
BUY
30 Nov 2018
Kelly David George
Director
Iterum Therapeutics plc
(ITRM)
19,548
+104%
10,000
$6.29
$62,887.00
BUY
30 Oct 2018
Chin Mark
Director
Iterum Therapeutics plc
(ITRM)
1,089,903
+5%
58,000
$6.10
$353,800.00
BUY
4 Sep 2018
Dunne Michael W.
Chief Scientific Officer, Officer
Iterum Therapeutics plc
(ITRM)
147,958
+0%
500
$10.00
$5,000.00
BUY
24 Aug 2018
Dunne Michael W.
Chief Scientific Officer, Officer
Iterum Therapeutics plc
(ITRM)
147,458
+0%
1,000
$10.00
$10,000.00
BUY
23 Aug 2018
Edick Paul R
Director
Iterum Therapeutics plc
(ITRM)
25,236
+2%
500
$10.44
$5,218.70
BUY
17 Aug 2018
Fishman Corey N.
President & CEO, Director, Officer
Iterum Therapeutics plc
(ITRM)
239,953
+0%
2,000
$8.73
$17,465.60
BUY
30 May 2018
Heron Patrick J
Director, 10% Owner
Iterum Therapeutics plc
(ITRM)
1,197,161
+61%
456,099
$13.00
$5,929,287.00
BUY
30 May 2018
Lathi Vijay K
10% Owner
Iterum Therapeutics plc
(ITRM)
1,071,688
+162%
662,677
$13.00
$8,614,801.00
BUY
30 May 2018
CANAAN X L.P.
Director, 10% Owner
Iterum Therapeutics plc
(ITRM)
1,733,170
+41%
506,656
$13.00
$6,586,528.00
BUY
30 May 2018
Sofinnova Venture Partners IX, L.P.
10% Owner
Iterum Therapeutics plc
(ITRM)
1,726,514
+40%
500,000
$13.00
$6,500,000.00
BUY
30 May 2018
HEALY JAMES
Director, 10% Owner
Iterum Therapeutics plc
(ITRM)
1,726,514
+40%
500,000
$13.00
$6,500,000.00
BUY
30 May 2018
Dunne Michael W.
Chief Scientific Officer, Officer
Iterum Therapeutics plc
(ITRM)
146,458
+1%
2,000
$13.00
$26,000.00
BUY
30 May 2018
Malik Shahzad
Director
Iterum Therapeutics plc
(ITRM)
29,836
+114%
236,984
$13.00
$3,080,792.00
BUY
30 May 2018
Ahrens Brenton Karl
Director
Iterum Therapeutics plc
(ITRM)
1,733,170
+41%
506,656
$13.00
$6,586,528.00
BUY
30 May 2018
HUNT RONALD
Director, 10% Owner
Iterum Therapeutics plc
(ITRM)
1,071,688
+162%
662,677
$13.00
$8,614,801.00
BUY
30 May 2018
Chin Mark
Director
Iterum Therapeutics plc
(ITRM)
1,031,903
+48%
337,606
$13.00
$4,388,878.00
BUY
30 May 2018
Matthews Judith M.
Chief Financial Officer, Officer
Iterum Therapeutics plc
(ITRM)
56,130
+7%
4,000
$13.00
$52,000.00
BUY
30 May 2018
Fishman Corey N.
President & CEO, Director, Officer
Iterum Therapeutics plc
(ITRM)
237,953
+1%
3,000
$13.00
$39,000.00
Home